Quantum-Si Given Buy Rating at HC Wainwright
QSI Stock | USD 1.25 0.11 9.65% |
Under 59% of all QuantumSi's traders are looking to take a long position. The analysis of the overall investor sentiment regarding QuantumSi suggests that some traders are interested. QuantumSi's investing sentiment shows overall attitude of investors towards QuantumSi.
QuantumSi |
HC Wainwright restated their buy rating on shares of Quantum-Si in a report issued on Wednesday morning,Benzinga reports. The firm currently has a 4.00 price objective on the stock. Separately, Canaccord Genuity Group lowered their price objective on Quantum-Si from 1.50 to 1.00 and set a hold rating for the company
Read at thelincolnianonline.com
QuantumSi Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards QuantumSi can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
QuantumSi Fundamental Analysis
We analyze QuantumSi's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of QuantumSi using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of QuantumSi based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
QuantumSi is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
QuantumSi Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with QuantumSi stock to make a market-neutral strategy. Peer analysis of QuantumSi could also be used in its relative valuation, which is a method of valuing QuantumSi by comparing valuation metrics with similar companies.
Peers
QuantumSi Related Equities
PASG | Passage Bio | 68.66 | ||||
NRIX | Nurix Therapeutics | 4.15 | ||||
BDTX | Black Diamond | 3.11 | ||||
MNOV | MediciNova | 2.99 | ||||
NTLA | Intellia Therapeutics | 2.70 | ||||
HRTX | Heron Therapeuti | 2.59 | ||||
EDIT | Editas Medicine | 1.82 | ||||
HOOK | Hookipa Pharma | 1.61 | ||||
ALEC | Alector | 1.57 | ||||
CRSP | Crispr Therapeutics | 0.65 | ||||
BEAM | Beam Therapeutics | 0.63 | ||||
ABOS | Acumen Pharmaceuticals | 0.44 | ||||
PRME | Prime Medicine, | 0.30 | ||||
CRBU | Caribou Biosciences | 0.45 | ||||
RNA | Avidity Biosciences | 0.69 | ||||
SEER | Seer | 1.20 | ||||
VERV | Verve Therapeutics | 2.94 | ||||
HCWB | HCW Biologics | 6.00 |
Complementary Tools for QuantumSi Stock analysis
When running QuantumSi's price analysis, check to measure QuantumSi's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy QuantumSi is operating at the current time. Most of QuantumSi's value examination focuses on studying past and present price action to predict the probability of QuantumSi's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move QuantumSi's price. Additionally, you may evaluate how the addition of QuantumSi to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |